The compounding pharmacy market is expected to grow to more than $18 billion by 2030, driven by an aging population, enhanced life expectancies, and increased demand for custom medications. Because the multi-step compounding process poses potential contamination risks that can jeopardize patient health, the industry is held to the strictest standards which are consistently scrutinized and adapted. This discussion will explore the most recent developments providers need to know and how they may be impacted.

Learning objectives:

1. Understand the recent updates to 503B compounding regulations and their implications for compounding practices and their processes.

2. Explain the criticality of staff training and maintaining consistent and transparent communication.

3. Learn strategies to comply with the new regulations and ensure patient safety for clinicians and administrators as well.

4. Analyze case studies and scenarios to apply knowledge of the revised regulations to real-world situations.